Home » Services » Preclinical studies » Novel in vivo model
Preclinical ocular model development

The basic research department of Iris Pharma develops and validates new in vivo models which can be used to select a lead compound for ophthalmic use, for proof of concept studies and to evaluate of the efficacy of ocular drugs or medical devices.

  • set up and validation of new in vivo models according to the specific requirements of our clients
  • improvement of existing models
  • exploring new in vivo models

We have already gained the trust of the largest pharmaceutical laboratories and of the most dynamic and successful biotechnology companies with nearly 50 in vivo models for investigating the various aspects of human's eye conditions: